1. Home
  2. PRK vs IRON Comparison

PRK vs IRON Comparison

Compare PRK & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park National Corporation

PRK

Park National Corporation

HOLD

Current Price

$179.11

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$65.65

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRK
IRON
Founded
1908
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
PRK
IRON
Price
$179.11
$65.65
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
★ $184.00
$103.18
AVG Volume (30 Days)
86.0K
★ 473.9K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
★ 2.61%
N/A
EPS Growth
★ 19.21
N/A
EPS
★ 5.64
N/A
Revenue
★ $664,421,000.00
N/A
Revenue This Year
$24.26
N/A
Revenue Next Year
$3.63
$283.52
P/E Ratio
$32.18
★ N/A
Revenue Growth
★ 2.92
N/A
52 Week Low
$149.06
$40.00
52 Week High
$215.00
$99.50

Technical Indicators

Market Signals
Indicator
PRK
IRON
Relative Strength Index (RSI) 30.22 28.72
Support Level $170.74 $65.04
Resistance Level $182.34 $72.68
Average True Range (ATR) 3.68 2.89
MACD -0.30 -0.50
Stochastic Oscillator 3.79 13.38

Price Performance

Historical Comparison
PRK
IRON

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: